Literature DB >> 17465017

Th17 and Th1 responses directed against the immunizing epitope, as opposed to secondary epitopes, dominate the autoimmune repertoire during relapses of experimental autoimmune encephalomyelitis.

Mark A Kroenke1, Benjamin M Segal.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating disease with similarities to multiple sclerosis (MS). It has been suggested that relapses of EAE and MS may be associated with, and even driven by, T cells specific for novel epitopes that are primed during the course of tissue destruction in the target organ or in secondary lymphoid tissues. We show, however, that IFNgamma and IL-17 responses against the immunizing epitope remain dominant through out the course of multiphasic EAE. Furthermore, induction of tolerance against a putative secondary epitope did not prevent clinical relapses. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465017     DOI: 10.1002/jnr.21291

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  18 in total

1.  Human endometrial-derived mesenchymal stem cells suppress inflammation in the central nervous system of EAE mice.

Authors:  J P S Peron; T Jazedje; W N Brandão; P M Perin; M Maluf; L P Evangelista; S Halpern; M G Nisenbaum; C E Czeresnia; M Zatz; N O S Câmara; L V Rizzo
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

2.  CNS-resident classical DCs play a critical role in CNS autoimmune disease.

Authors:  David A Giles; Patrick C Duncker; Nicole M Wilkinson; Jesse M Washnock-Schmid; Benjamin M Segal
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

3.  Low-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells.

Authors:  Michael W Y Chan; Chia-Bin Chang; Chien-Hsueh Tung; Justin Sun; Jau-Ling Suen; Shu-Fen Wu
Journal:  Mol Med       Date:  2014-06-26       Impact factor: 6.354

4.  Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis.

Authors:  Mario Skarica; Tianhong Wang; Erin McCadden; David Kardian; Peter A Calabresi; Donald Small; Katharine A Whartenby
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

5.  Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis.

Authors:  Jingxian Yang; Zhilong Jiang; Denise C Fitzgerald; Cungen Ma; Shuo Yu; Hongmei Li; Zhao Zhao; Yonghai Li; Bogoljub Ciric; Mark Curtis; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  J Clin Invest       Date:  2009-11-02       Impact factor: 14.808

6.  Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Authors:  Michael C Levin; Sangmin Lee; Lidia A Gardner; Yoojin Shin; Joshua N Douglas; Chelsea Cooper
Journal:  J Clin Cell Immunol       Date:  2013-06-30

Review 7.  Modeling the heterogeneity of multiple sclerosis in animals.

Authors:  Sarah B Simmons; Emily R Pierson; Sarah Y Lee; Joan M Goverman
Journal:  Trends Immunol       Date:  2013-05-21       Impact factor: 16.687

Review 8.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Authors:  A Arévalo-Martín; D García-Ovejero; O Gómez; A Rubio-Araiz; B Navarro-Galve; C Guaza; E Molina-Holgado; F Molina-Holgado
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

9.  Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice.

Authors:  Silvy Mardiguian; Sébastien Serres; Emma Ladds; Sandra J Campbell; Panop Wilainam; Charles McFadyen; Martina McAteer; Robin P Choudhury; Paul Smith; Fay Saunders; Gillian Watt; Nicola R Sibson; Daniel C Anthony
Journal:  Am J Pathol       Date:  2013-04-16       Impact factor: 4.307

10.  Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases.

Authors:  Xuebin Liu; Yun Sang Lee; Cheng-Rong Yu; Charles E Egwuagu
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.